ArticleInvestigative ophthalmology & visual science2026
Adalimumab Reprograms M1 Macrophages to Attenuate Th1/Th17 Responses in Behçet's Uveitis and Vogt-Koyanagi-Harada Syndrome.
Yunyun Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.